Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
1345.HK
Strong BuyShanghai Pioneer Holding Ltd · Healthcare · China · $331M · Avg Vol: $14K/d
99
StockRankGet insider-trade alerts
Q
74
V
68
M
75
P/E (TTM)
18.7x
ROE
9.7%
D/E
0.1x
Dividend %
5.3%
COMPANY DESCRIPTION
Shanghai Pioneer Holding Ltd, an investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People's Republic of China.
FINANCIAL SUMMARY (HKD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1.8B | 1.8B | 1.8B | 1.5B | -6.2% | 1.5B |
| EPS (HKD) | 0.23 | 0.14 | 0.15 | 0.12 | -20.6% | 0.12 |
| Shares | 1.3B | 1.2B | 1.2B | 1.2B | -7.8% | 1.2B |
| Debt | 43.9M | 86.3M | 87.7M | 141.6M | 47.8% | 141.6M |
| Equity | 1.2B | 1.2B | 1.3B | 1.2B | 1.4% | — |
| Op CF | 108.8M | -138.4M | 250.6M | 244.2M | 30.9% | 244.2M |
| Inv CF | -15.2M | 81.1M | -116.4M | -97.3M | — | — |
| Fin CF | -106.2M | -59.0M | -146.9M | -73.3M | — | — |
Loading 1Y...
PRICE (1Y)+0.4%
SMA 50SMA 200
Close
$0.2857
RSI (14)
51.1
52W High
$0.2988
From 52W High
1.0%
SCORE BREAKDOWN
Quality
74
ROIC
12.7%80.3
ROE
9.7%71.3
GP/Assets
42.1%80.9
Op. Margin
11.4%68.0
FCF/Assets
12.0%89.7
Piotroski
550.3
Int. Cover
50.0x89.3
D/E Ratio
0.12x60.5
Current Ratio
3.22x57.2
Value
68
P/E (TTM)
18.7x62.2
EV/EBITDA
12.7x56.4
P/FCF
12.4x77.4
P/B
1.8x64.7
P/S
1.7x71.8
Div Yield
5.3%90.7
Momentum
75
52W High %
96%93.1
RS 6M
7%70.4
SMA 50/200
1.02x65.9
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
19%56.0
FUNDAMENTALS
Market Cap
$331M
P/E (Forward)
—
Gross Margin
48.9%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 1345.HK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 1345.HK | Shanghai Pioneer Holding Ltd(you) | $331M | 99 | Strong Buy |
| 9885.HK | YSB Inc. | $316M | 77 | Buy |
| 002727.SZ | Yixintang Pharmaceutical Group Co., Ltd. | $1.0B | 90 | Strong Buy |
| 603883.SS | LBX Pharmacy Chain Joint Stock Company | $1.5B | 89 | Strong Buy |
| 603233.SS | DaShenLin Pharmaceutical Group Co., Ltd. | $3.1B | 95 | Strong Buy |
| 603939.SS | Yifeng Pharmacy Chain Co., Ltd. | $4.3B | 91 | Strong Buy |
| 301408.SZ | Anhui Huaren Health Pharmaceutical Co., Ltd. | $915M | 60 | Hold |
| 002788.SZ | Luyan Pharma Co.,Ltd. | $651M | 50 | Hold |
| 301017.SZ | ShuYu Civilian Pharmacy Corp., Ltd. | $804M | 40 | Hold |
| 6086.HK | Fangzhou Inc. | $122M | 36 | Hold |
Peer medians: ROE 4.5% · P/E 29.0x · Gross margin 52.6%